Trial Profile
Efficacy and safety of switching of anti-retroviral agents to Emtricitabine/tenofovir-disoproxil-fumarate in HIV-infected Taiwanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir; Lamivudine/tenofovir-disoproxil-fumarate; Lamivudine/zidovudine
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 30 Dec 2016 New trial record